Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
GKOS News
Loading... Loading... Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from $(0.59) a year ago, missing the consens...
Glaukos (GKOS) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.59 per shar...
Glaukos (GKOS) has shared an update. Glaukos Corporation has released its first-quarter financial summary for 2024, offering investors a glimpse into the compa...
Analyst ratings
67%
of 15 ratingsMore GKOS News
Reports Q1 revenue $85.6M, consensus $79.6M. “Our record first quarter results reflect successful global execution of our key strategic plans,” said Thomas Burn...
ALISO VIEJO, Calif., May 01, 2024--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on nov...